Microvisk Technologies

Microvisk Technologies develops innovative point-of-care diagnostic devices using patented MEMS sensor platforms to enable rapid blood clotting tests outside traditional laboratories—primarily serving patients requiring regular anticoagulant therapy monitoring through PT/INR measurements. Their flagship product “CoagMax” leverages unique disposable “Smart Strips” that require minimal blood volume while providing high accuracy through embedded calibration/QC features. Clinical trials with the Royal London Hospital demonstrated excellent results compared to laboratory standards. The system includes built-in quality controls and memory chips for calibration and traceability. The company remains active as a privately held UK business focused on hematology diagnostics.